Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study
Twelve parkinsonian patients with severely fluctuating symptoms were given a single dose of apomorphine or Dispersible Madopar on 2 consecutive days, to confirm the latter drug's usefulness in 'off' period rescue. According to our results, apomorphine proved faster in reverting '...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | JOUR |
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_03625664_v20_n2_p165_Merello |
Aporte de: |
id |
todo:paper_03625664_v20_n2_p165_Merello |
---|---|
record_format |
dspace |
spelling |
todo:paper_03625664_v20_n2_p165_Merello2023-10-03T15:27:25Z Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study Merello, M. Pikielny, R. Cammarota, A. Leiguarda, R. 'On-off' periods Apomorphine Dispersible Madopar Motor fluctuation Parkinson's disease apomorphine benserazide plus levodopa britaject levodopa unclassified drug adult article clinical article clinical trial controlled clinical trial controlled study double blind procedure female human male motor dysfunction on off phenomenon Parkinson disease priority journal subcutaneous drug administration Twelve parkinsonian patients with severely fluctuating symptoms were given a single dose of apomorphine or Dispersible Madopar on 2 consecutive days, to confirm the latter drug's usefulness in 'off' period rescue. According to our results, apomorphine proved faster in reverting 'off' periods and should still be regarded as the drug of choice for this treatment modality. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_03625664_v20_n2_p165_Merello |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
topic |
'On-off' periods Apomorphine Dispersible Madopar Motor fluctuation Parkinson's disease apomorphine benserazide plus levodopa britaject levodopa unclassified drug adult article clinical article clinical trial controlled clinical trial controlled study double blind procedure female human male motor dysfunction on off phenomenon Parkinson disease priority journal subcutaneous drug administration |
spellingShingle |
'On-off' periods Apomorphine Dispersible Madopar Motor fluctuation Parkinson's disease apomorphine benserazide plus levodopa britaject levodopa unclassified drug adult article clinical article clinical trial controlled clinical trial controlled study double blind procedure female human male motor dysfunction on off phenomenon Parkinson disease priority journal subcutaneous drug administration Merello, M. Pikielny, R. Cammarota, A. Leiguarda, R. Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study |
topic_facet |
'On-off' periods Apomorphine Dispersible Madopar Motor fluctuation Parkinson's disease apomorphine benserazide plus levodopa britaject levodopa unclassified drug adult article clinical article clinical trial controlled clinical trial controlled study double blind procedure female human male motor dysfunction on off phenomenon Parkinson disease priority journal subcutaneous drug administration |
description |
Twelve parkinsonian patients with severely fluctuating symptoms were given a single dose of apomorphine or Dispersible Madopar on 2 consecutive days, to confirm the latter drug's usefulness in 'off' period rescue. According to our results, apomorphine proved faster in reverting 'off' periods and should still be regarded as the drug of choice for this treatment modality. |
format |
JOUR |
author |
Merello, M. Pikielny, R. Cammarota, A. Leiguarda, R. |
author_facet |
Merello, M. Pikielny, R. Cammarota, A. Leiguarda, R. |
author_sort |
Merello, M. |
title |
Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study |
title_short |
Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study |
title_full |
Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study |
title_fullStr |
Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study |
title_full_unstemmed |
Comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: A double-blind single-dose study |
title_sort |
comparison of subcutaneous apomorphine versus dispersible madopar latency and effect duration in parkinson's disease patients: a double-blind single-dose study |
url |
http://hdl.handle.net/20.500.12110/paper_03625664_v20_n2_p165_Merello |
work_keys_str_mv |
AT merellom comparisonofsubcutaneousapomorphineversusdispersiblemadoparlatencyandeffectdurationinparkinsonsdiseasepatientsadoubleblindsingledosestudy AT pikielnyr comparisonofsubcutaneousapomorphineversusdispersiblemadoparlatencyandeffectdurationinparkinsonsdiseasepatientsadoubleblindsingledosestudy AT cammarotaa comparisonofsubcutaneousapomorphineversusdispersiblemadoparlatencyandeffectdurationinparkinsonsdiseasepatientsadoubleblindsingledosestudy AT leiguardar comparisonofsubcutaneousapomorphineversusdispersiblemadoparlatencyandeffectdurationinparkinsonsdiseasepatientsadoubleblindsingledosestudy |
_version_ |
1807314416826318848 |